Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 July 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 206 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 702 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is L  [Clear All Filters]
2017
F. X. Lamy, Saragoussi, D., Johnson, M. E., Guiraud-Diawara, A., Jorgensen, K. T., Loze, J. Y., and Maguire, A., The use of adjunctive antipsychotics to treat depression in UK primary care, Curr Med Res Opin, vol. 33, pp. 891-898, 2017.
F. X. Lamy, Saragoussi, D., Johnson, M. E., Guiraud-Diawara, A., Jorgensen, K. T., Loze, J. Y., and Maguire, A., The use of adjunctive antipsychotics to treat depression in UK primary care, Curr Med Res Opin, vol. 33, pp. 891-898, 2017.
L. M. Knapen, de Jong, R. G., Driessen, J. H., Keulemans, Y. C., van Erp, N. P., De Bruin, M. L., Leufkens, H. G., Croes, S., and de Vries, F., Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study, Diabetes Obes Metab, vol. 19, pp. 401-411, 2017.
J. Gorricho, Garjon, J., Alonso, A., Celaya, M. C., Saiz, L. C., Erviti, J., and Lopez, A., Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study, Br J Clin Pharmacol, vol. 83, pp. 2034-2044, 2017.
T. A. Durham, K. Lich, H., Viera, A. J., Fine, J. P., Mukherjee, J., Weinberger, M., and Dusetzina, S. B., Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation, Am J Cardiol, vol. 120, pp. 1820-1829, 2017.
I. Little, Vinogradova, Y., Orton, E., Kai, J., and Qureshi, N., Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysis, BMJ Open, vol. 7, p. e012665, 2017.
2016
K. Jameson, D'Oca, K., Leigh, P., and Murray-Thomas, T., Adherence to NICE guidance on glucagon-like peptide-1 receptor agonists among patients with type 2 diabetes mellitus: an evaluation using the Clinical Practice Research Datalink, Curr Med Res Opin, vol. 32, pp. 49-60, 2016.
A. J. Farmer, Rodgers, L. R., Lonergan, M., Shields, B., Weedon, M. N., Donnelly, L., Holman, R. R., Pearson, E. R., and Hattersley, A. T., Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database, Diabetes Care, vol. 39, pp. 258-263, 2016.
S. Hawley, Leal, J., Delmestri, A., Prieto-Alhambra, D., Arden, N. K., Cooper, C., Javaid, M. K., and Judge, A., Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis, J Bone Miner Res, vol. 31, pp. 2008-2015, 2016.
L. Alexandre, Clark, A. B., Bhutta, H. Y., Chan, S. S., Lewis, M. P., and Hart, A. R., Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study, Gastroenterology, vol. 150, pp. 854-65.e1; quiz e16-7, 2016.
F. Rees, Doherty, M., Grainge, M., Lanyon, P., Davenport, G., and Zhang, W., Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999-2012, Arthritis Care Res (Hoboken), vol. 68, pp. 819-27, 2016.
S. L. Stevens, Stevens, R. J., Hobbs, F. D., and Lasserson, D. S., Chronic renal disease is not chronic kidney disease: implications for use of the QRISK and Joint British Societies risk scores, Fam Pract, vol. 33, pp. 57-60, 2016.
L. Watson, Das, R., Farquhar, R., Langerman, H., and Barnett, A. H., Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database, Curr Med Res Opin, vol. 32, pp. 1465-75, 2016.
A. W. Lim, Landy, R., Castanon, A., Hollingworth, A., Hamilton, W., Dudding, N., and Sasieni, P., Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review, Br J Gen Pract, vol. 66, pp. e871-e879, 2016.
A. W. Lim, Landy, R., Castanon, A., Hollingworth, A., Hamilton, W., Dudding, N., and Sasieni, P., Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review, Br J Gen Pract, vol. 66, pp. e871-e879, 2016.
A. Tebboth, Lee, S., Scowcroft, A., Bingham-Gardiner, P., Spencer, W., Bolodeoku, J., and Hassan, S. W., Demographic and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Initiating Dipeptidyl Peptidase 4 Inhibitors: A Retrospective Study of UK General Practice, Clin Ther, vol. 38, pp. 1825-1832.e15, 2016.
A. A. Sultan, West, J., Grainge, M. J., Riley, R. D., Tata, L. J., Stephansson, O., Fleming, K. M., Nelson-Piercy, C., and Ludvigsson, J. F., Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study, Bmj, vol. 355, p. i6253, 2016.
C. Seliger, Ricci, C., Meier, C. R., Bodmer, M., Jick, S. S., Bogdahn, U., Hau, P., and Leitzmann, M. F., Diabetes, use of antidiabetic drugs, and the risk of glioma, Neuro Oncol, vol. 18, pp. 340-9, 2016.
C. Renzi, Lyratzopoulos, G., Card, T., Chu, T. P., Macleod, U., and Rachet, B., Do colorectal cancer patients diagnosed as an emergency differ from non-emergency patients in their consultation patterns and symptoms? A longitudinal data-linkage study in England, Br J Cancer, vol. 115, pp. 866-75, 2016.
M. E. Johnson, Lefevre, C., Collings, S. L., Evans, D., Kloss, S., Ridha, E., and Maguire, A., Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care, BMJ Open, vol. 6, p. e011471, 2016.
I. Barker, Lloyd, T., and Steventon, A., Effect of a national requirement to introduce named accountable general practitioners for patients aged 75 or older in England: regression discontinuity analysis of general practice utilisation and continuity of care, BMJ Open, vol. 6, p. e011422, 2016.
T. Lloyd and Steventon, A., Effect of Named, Accountable GPs on Continuity of Care: Protocol for a Regression Discontinuity Study of a National Policy Change, Int J Integr Care, vol. 16, p. 6, 2016.
C. Cohet, Haguinet, F., G. Santos, D., Webb, D., Logie, J., G. Ferreira, L., Rosillon, D., and Shinde, V., Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series, BMJ Open, vol. 6, p. e009264, 2016.
D. Juszczyk, Charlton, J., McDermott, L., Soames, J., Sultana, K., Ashworth, M., Fox, R., Hay, A. D., Little, P., Moore, M. V., Yardley, L., Prevost, A. T., and Gulliford, M. C., Electronically delivered, multicomponent intervention to reduce unnecessary antibiotic prescribing for respiratory infections in primary care: a cluster randomised trial using electronic health records-REDUCE Trial study original protocol, BMJ Open, vol. 6, p. e010892, 2016.
M. Happich, Kirson, N. Y., Desai, U., King, S., Birnbaum, H. G., Reed, C., Belger, M., Lenox-Smith, A., and Price, D., Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population, J Alzheimers Dis, vol. 53, pp. 171-83, 2016.
G. Requena, Huerta, C., Gardarsdottir, H., Logie, J., Gonzalez-Gonzalez, R., Abbing-Karahagopian, V., Miret, M., Schneider, C., Souverein, P. C., Webb, D., Afonso, A., Boudiaf, N., Martin, E., Oliva, B., Alvarez, A., de Groot, M. C., Bate, A., Johansson, S., Schlienger, R., Reynolds, R., Klungel, O. H., and de Abajo, F. J., Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 66-78, 2016.
A. M. Gallagher, Williams, T., Leufkens, H. G., and de Vries, F., The Impact of the Choice of Data Source in Record Linkage Studies Estimating Mortality in Venous Thromboembolism, PLoS One, vol. 11, p. e0148349, 2016.
K. C. Chang, Lee, J. T., Vamos, E. P., Soljak, M., Johnston, D., Khunti, K., Majeed, A., and Millett, C., Impact of the National Health Service Health Check on cardiovascular disease risk: a difference-in-differences matching analysis, Cmaj, vol. 188, pp. E228-38, 2016.
F. Rees, Doherty, M., Grainge, M., Davenport, G., Lanyon, P., and Zhang, W., The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012, Ann Rheum Dis, vol. 75, pp. 136-41, 2016.
K. W. Hagberg, Li, L., Peng, M., Shah, K., Paris, M., and Jick, S., Incidence rates of suicidal behaviors and treated depression in patients with and without psoriatic arthritis using the Clinical Practice Research Datalink, Mod Rheumatol, vol. 26, pp. 774-9, 2016.
D. M. Fleming, Taylor, R. J., Haguinet, F., Schuck-Paim, C., Logie, J., Webb, D. J., Lustig, R. L., and Matias, G., Influenza-attributable burden in United Kingdom primary care, Epidemiol Infect, vol. 144, pp. 537-47, 2016.
D. M. Fleming, Taylor, R. J., Haguinet, F., Schuck-Paim, C., Logie, J., Webb, D. J., Lustig, R. L., and Matias, G., Influenza-attributable burden in United Kingdom primary care, Epidemiol Infect, vol. 144, pp. 537-47, 2016.
A. G. Boef, Souverein, P. C., Vandenbroucke, J. P., A. Vlieg, vanHylckama, de Boer, A., le Cessie, S., and Dekkers, O. M., Instrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptives, Pharmacoepidemiol Drug Saf, vol. 25, pp. 317-24, 2016.
P. J. Peeters, Bazelier, M. T., Leufkens, H. G., Auvinen, A., van Staa, T. P., de Vries, F., and De Bruin, M. L., Insulin glargine use and breast cancer risk: Associations with cumulative exposure, Acta Oncol, vol. 55, pp. 851-8, 2016.
S. D'Angelo, Coggon, D., Harris, E. C., Linaker, C., Sayer, A. A., Gale, C. R., Evandrou, M., Van Staa, T., Cooper, C., Walker-Bone, K., and Palmer, K. T., Job dissatisfaction and the older worker: baseline findings from the Health and Employment After Fifty study, Occup Environ Med, vol. 73, pp. 512-9, 2016.
J. Drahos, Li, L., Jick, S. S., and Cook, M. B., Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink, Cancer Epidemiol, vol. 42, pp. 9-14, 2016.
S. Taylor, Taylor, R. J., Lustig, R. L., Schuck-Paim, C., Haguinet, F., Webb, D. J., Logie, J., Matias, G., and Fleming, D. M., Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK, BMJ Open, vol. 6, p. e009337, 2016.
S. Taylor, Taylor, R. J., Lustig, R. L., Schuck-Paim, C., Haguinet, F., Webb, D. J., Logie, J., Matias, G., and Fleming, D. M., Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK, BMJ Open, vol. 6, p. e009337, 2016.
A. Judge, Javaid, M. K., Leal, J., Hawley, S., Drew, S., Sheard, S., Prieto-Alhambra, D., Gooberman-Hill, R., Lippett, J., Farmer, A., Arden, N., Gray, A., Goldacre, M., Delmestri, A., and Cooper, C., Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England, Health Services and Delivery Research, vol. No. 4.28, 2016.
A. Judge, Javaid, M. K., Leal, J., Hawley, S., Drew, S., Sheard, S., Prieto-Alhambra, D., Gooberman-Hill, R., Lippett, J., Farmer, A., Arden, N., Gray, A., Goldacre, M., Delmestri, A., and Cooper, C., Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England, Health Services and Delivery Research, vol. No. 4.28, 2016.
F. Rees, Doherty, M., Grainge, M. J., Lanyon, P., Davenport, G., and Zhang, W., Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012, Rheumatology (Oxford), vol. 55, pp. 854-60, 2016.
T. Wilke, Mueller, S., Groth, A., Berg, B., Fuchs, A., Sikirica, M., Logie, J., Martin, A., and Maywald, U., Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis, Diabetes Ther, vol. 7, pp. 105-24, 2016.
M. Movahedi, Costello, R., Lunt, M., Pye, S. R., Sergeant, J. C., and Dixon, W. G., Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort study, Eur J Epidemiol, vol. 31, pp. 1045-1055, 2016.
A. Lane, Metcalfe, C., Young, G. J., Peters, T. J., Blazeby, J., Avery, K. N., Dedman, D., Down, L., Mason, M. D., Neal, D. E., Hamdy, F. C., and Donovan, J. L., Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life, BJU Int, vol. 118, pp. 869-879, 2016.
A. W. Lim, Hamilton, W., Hollingworth, A., Stapley, S., and Sasieni, P., Performance characteristics of visualising the cervix in symptomatic young females: a review of primary care records in females with and without cervical cancer, Br J Gen Pract, vol. 66, pp. e189-92, 2016.
A. Matthews, Langan, S. M., Douglas, I. J., Smeeth, L., and Bhaskaran, K., Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink, PLoS Med, vol. 13, p. e1002037, 2016.
Y. Lian, Yin, H., Pollak, M. N., Carrier, S., Platt, R. W., Suissa, S., and Azoulay, L., Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer, Eur Urol, vol. 70, pp. 808-815, 2016.
P. Korhonen, Heintjes, E. M., Williams, R., Hoti, F., Christopher, S., Majak, M., Kool-Houweling, L., Strongman, H., Linder, M., Dolin, P., and Bahmanyar, S., Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries, Bmj, vol. 354, p. i3903, 2016.
S. A. Julious, Horspool, M. J., Davis, S., Bradburn, M., Norman, P., Shephard, N., Cooper, C. L., Smithson, W. H., Boote, J., Elphick, H., Loban, A., Franklin, M., Kua, W. S., May, R., Campbell, J., Williams, R., Rex, S., and Bortolami, O., PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term - a cluster randomised controlled trial and economic evaluation, Health Technol Assess, vol. 20, pp. 1-154, 2016.
C. Klop, de Vries, F., Bijlsma, J. W., Leufkens, H. G., and Welsing, P. M., Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density, Ann Rheum Dis, vol. 75, pp. 2095-2100, 2016.
[Page last reviewed 6 July 2020]